Connect Biopharma Holdings Limited Expense Relating To Shortterm Leases For Which Recognition Exemption Has Been Used
Connect Biopharma Holdings Limited (CNTB) reported Expense Relating To Shortterm Leases For Which Recognition Exemption Has Been Used of $0 for the 12-month period ending 2023-12-31, per its 20-F filed 2024-04-16.
Discontinued › Expense Statement › Operating Expenses
ifrs-full:ExpenseRelatingToShorttermLeasesForWhichRecognitionExemptionHasBeenUsed · last filed 2024-04-16
CNY
| Period end | Expense Relating To Shortterm Leases For Which Recognition Exemption Has Been Used 6 month | Expense Relating To Shortterm Leases For Which Recognition Exemption Has Been Used 12 month |
|---|---|---|
| 2021-12-31 | 12.00K CNY 20-F · filed 2023-04-11 | |
| 2021-06-30 | 17.00K CNY 6-K · filed 2022-09-13 | |
| 2020-12-31 | 45.00K CNY 20-F · filed 2023-04-11 | |
| 2019-12-31 | 98.00K CNY 20-F · filed 2022-03-31 |
USD
| Period end | Expense Relating To Shortterm Leases For Which Recognition Exemption Has Been Used 12 month |
|---|---|
| 2023-12-31 | $0.00 20-F · filed 2024-04-16 |
| 2022-12-31 | $0.00 20-F · filed 2024-04-16 |
| 2021-12-31 | $2.00K 20-F · filed 2024-04-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |